CNIC researcher Florian Weinberger awarded ERC Advanced Grant for the project CARDIOSWITCH
Grant and Award Announcement
Updates every hour. Last Updated: 31-Oct-2026 18:16 ET (31-Oct-2026 22:16 GMT/UTC)
Florian Weinberger conducts his research within the Regeneration Program at the CNIC.
The Hebrew University of Jerusalem proudly congratulates Prof. Yuval Dor and Dr. Agnès Klochendler of the Faculty of Medicine, The Institute for Medical Research Israel-Canada on being awarded the highly competitive European Research Council (ERC) Advanced Grant.
• Huntington’s disease is a genetic disorder that gradually destroys brain cells over the course of 10 to 30 years, typically starting between the ages of 35 and 50
• Phase 1b/2a will evaluate the safety of the treatment and provides hope for those with few options to slow the progression of the disease
• Clinical trial will enroll 21 people with early-stage Huntington’s disease, with 12 participants in a phase 1b dose-escalation group and nine in a phase 2a expansion group
Reported June 23 in Nature Biomedical Engineering, researchers at Vanderbilt Health and centers in Hong Kong have created a versatile uncertainty-aware AI framework broadly adaptable as a wrapper for digital pathology AI systems. (An AI wrapper acts as an interface layer that customizes, formats and automates how users interact with the underlying intelligence.) They demonstrate their wrapper, called TRUECAM, primarily with reference to non-small cell lung cancer (NSCLC) subtyping using whole-slide images.
UCLA scientists are calling for a large-scale initiative to understand how human cells influence one another — a missing layer of biology that could reveal how cellular interactions drive disease and inform new therapies.